SEMAX
Targeted Peptide Therapy // IVUSE+

SEMAX

Semax. A 7-amino acid synthetic analog of ACTH(4-10) that upregulates BDNF in the hippocampus within hours of administration. Not a stimulant. A neurotrophic signal.

10MG/ML
BDNF Upregulation Cognitive Enhancement Neuroprotection Dopamine + Serotonin Modulation

Clinician-prescribed. Ships from a licensed U.S. pharmacy.

The Mechanism

Your Brain Isn't Slow. It's Undersupplied.

Cognitive decline is a supply problem. The brain depends on neurotrophic factors to maintain synaptic connections and form new ones. BDNF is the most critical. When levels drop, connections weaken, flexibility erodes, and the brain becomes less resilient to stress and aging. Semax intervenes at this supply level, restoring the signal the pituitary produces specifically for neural maintenance. After administration, Semax crosses the blood-brain barrier and triggers a cascade: BDNF gene transcription increases 3-fold, TrkB receptors double, serotonin metabolites climb to 180% of baseline. Stimulants force the system to output more than it can sustain. Semax gives the system what it needs to operate at capacity.

Clinical Data

The Evidence

7 Amino Acids
Smallest functional neuropeptide in the IVUSE catalog, engineered for blood-brain barrier penetration
4 Parallel Pathways
BDNF upregulation, serotonergic activation, dopaminergic modulation, enkephalin preservation
71% vs. 41%
Memory accuracy in fatigued volunteers, Semax vs. controls, persisting 24 hours
Kaplan et al. Human volunteer study, Semax cognitive performance trial
Comparison

Conventional Cognitive Enhancement vs. Semax (ACTH 4-10 Analog)

Conventional Cognitive EnhancementSemax (ACTH 4-10 Analog)
Caffeine delays fatigue perception but creates tolerance and disrupts sleep 3-fold increase in hippocampal BDNF gene transcription from a single dose
Modafinil promotes wakefulness but does not upregulate neurotrophic factors Zero hormonal activity despite ACTH derivation, no endocrine side effects
Amphetamine stimulants force dopamine release and create dependence Simultaneous serotonin, dopamine, and enkephalin modulation from one peptide
Racetam nootropics have inconsistent evidence and no BDNF effect Non-habit-forming with no tolerance, dependence, or withdrawal
Supplement stacks work indirectly and produce modest gains that plateau Modulates over 1,500 genes, activating neurotrophin transcription selectively
Each approach forces output from a depleted system or provides indirect support Government-approved pharmaceutical in Russia since 1996, three decades of safety data
Product Information

Details

Semax is a synthetic heptapeptide derived from the 4-10 fragment of adrenocorticotropic hormone (ACTH). Developed in the 1980s at the Institute of Molecular Genetics of the Russian Academy of Sciences, it has been approved as a pharmaceutical in Russia since 1996 for stroke, cognitive disorders, and optic nerve disease. Native ACTH(4-10) degrades within 30-60 minutes. The addition of a C-terminal Pro-Gly-Pro tripeptide extends biological duration to 20-24 hours while keeping the molecule at 813.92 Daltons, small enough to cross the blood-brain barrier efficiently after subcutaneous injection. Semax operates through four parallel pathways: BDNF/TrkB upregulation in the hippocampus, serotonergic activation, dopaminergic modulation for executive function, and enkephalin preservation for stress resilience. Despite ACTH derivation, it has zero hormonal activity. No cortisol stimulation. No adrenal axis disruption.
BDNF is the master regulator of neuroplasticity, governing neuronal survival and the long-term potentiation underlying learning and memory. A single dose of Semax produced a 3-fold increase in BDNF gene transcription, 1.4x increase in BDNF protein, and 2x increase in TrkB receptor mRNA. The brain both produces more BDNF and becomes more responsive to it. Beyond BDNF, Semax potentiates dopaminergic signaling in prefrontal circuits without forcing dopamine release. Genome-wide analysis shows it modulates over 1,500 genes, selectively activating neurotrophin transcription in stressed neural tissue.
Administer via subcutaneous injection using a 27-31 gauge insulin syringe. Inject into the abdomen, upper arm, or thigh. Rotate injection sites. Standard protocol involves 10-14 day cycles with rest intervals between courses. Store refrigerated at 36 to 46 degrees Fahrenheit. Protect from light. Do not freeze.
Semax has been used clinically in Russia for nearly three decades with an exceptional safety profile. The most common effects are mild injection site irritation, occasional headache, and rare transient restlessness. Non-habit-forming with no dependence, tolerance, or withdrawal.
Disclaimer and Transparency

Important Information About Compounded Injectables

  • Compounded medications are not reviewed or approved by the FDA and do not undergo the same pre-market evaluation as FDA-approved drugs.
  • IVUSE peptide injections are prepared using peptide ingredients by FDA-registered, U.S.-licensed 503A & 503B compounding pharmacies, where available and clinically appropriate.
  • Availability and formulation may vary based on state regulations, evolving clinical guidance, and pharmacy partners.

All prescriptions, treatment decisions, and care plans are made independently by licensed healthcare providers using their professional judgment. Images and product depictions are for illustration only; actual packaging and supplies may vary.

*If you are interested in a prescription product, IVUSE will coordinate a telehealth visit with a licensed medical provider who will determine whether you are an appropriate candidate based on your health profile and current standards of care. If approved, a prescription will be issued and filled by one of our partner pharmacies. All prescriptions are subject to provider discretion and clinical appropriateness.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. All information provided here is for educational purposes only and does not replace personalized medical advice from a qualified healthcare professional.

Stop the medication and contact your provider if you experience persistent or concerning symptoms. Seek immediate medical care if you develop signs of a severe allergic reaction (such as hives, facial swelling, or difficulty breathing) or any rapidly worsening symptom.

After You Order

What happens next

01

Choose Your Protocol

No consultation fee. No hidden costs. Single vials or a full 12-week cycle.

02

Complete Your Clinical Intake

A board-certified clinician reviews your health history, medications, and goals. Asynchronous. No appointments. No waiting rooms.

03

Your Prescription Ships

Compounded by a licensed U.S. pharmacy. Delivered to your door in 2-4 business days. Cold-shipped when required.

Clinical Recommendation

Stack Your Protocol

SELANK
Peptide Therapy

SELANK

Enhances nootropic effects, mood regulation, and cognitive recovery. Selank calms anxiety and inflammation while Semax sharpens focus and elevates BDNF, covering both sides of cognitive performance.

Starting at $126.00
BPC-157
Peptide Therapy

BPC-157

Supports neuroregeneration and recovery from stress-induced inflammation. BPC-157 repairs the neural environment while Semax drives the BDNF signaling that rebuilds it.

Starting at $129.00
NAD+
Peptide Therapy

NAD+

Longevity and mitochondrial resilience for the brain. NAD+ fuels the cellular energy Semax needs to sustain neurotransmitter release and BDNF activity.

Starting at $141.00

SEMAX

SEMAX $72.00